More notable recent ChromaDex Corporation (NASDAQ:CDXC) news were published by: Marketwatch.com which released: “ChromaDex Corp.” on January 19, 2017, also Globenewswire.com with their article: “Published Study Reveals NIAGEN® Nicotinamide Riboside is ...
more»